TrialJournal of acquired immune deficiency syndromes (1999)2017

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults.

Gregory D Huhn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.